Table 1.
Primers used in this study.
| Name | Sequence of primers (5’-3’) | Product size (bp) |
|---|---|---|
| DEV-UL2 [21] | F: ACGAGGGAGACCCAAATGAC | 1018/493a |
| R: TTTATACTGTTCCACAAGGAAGTTG | ||
| DEV-LORF5 [9] | F: GATGAATCTCCTCCGCCAT | 2454/525b |
| R: GTACGTGGTGTAGCCGAAT | ||
| MDPV [22] | F: AATGCTGTAGTGCAGGAGGA | 1197 |
| R: ACAATCATACCACCCATGTT | ||
| DHAV [23] | F: CTTTCCACTCCCTGCTCCC | 140 |
| R: TTGGCTTCCACATCCTCTTCA | ||
| AIV [23] | F: GGCGACTACTACCAACCCA | 435 |
| R: CTGCTGTTCCTGCCGATAT | ||
| DuCV [24] | F: GCACGCTCGACAATTGCAAGT | 338 |
| R: GCCACGCCCAAAGATTACATAAG | ||
| DTMUV [23] | F: AATCGGTAGTGGCTTTGG | 288 |
| R: AGTCTGCCGACATGGATAT | ||
| WRV [25] | F: TGAATGGTGGAACGCCTGTGCACGAG | 300 |
| R: ACGCCTAGACGGTAAAAGTGGCTAG | ||
| DAstV [26] | F: CTTGGACTGTGGAAGCATATACC | 763 |
| R: GTTGAAAACTGCCCTGAAGG | ||
| GPV [22] | F: AGCCTAAGAGAAGCARGAACA | 161 |
| R: ACAATCATACCACCCATGTT | ||
| DAdV-1 [27] | F: CTGACCCAAGATGGTGAAT | 403 |
| R: GCAACCTTTGCTGCTTTGTTC | ||
| DAdV-2 [27] | F: GGTCTTGGAGTAGTAGTAAAC | 418 |
| R: CCAACCCGTCATTATTTCTTATC | ||
| DAdV-3 [27] | F: ATGGCCGCTCTGACCCCTGA | 640 |
| R: ATTCAGCCTTAGCTACTTTC | ||
| DAdV-4 [27] | F: TCCACCTAGACGAAACTATG | 532 |
| R: GTCGTGGCGTCGTTGTCGC |
aThe PCR fragment is 1018 bp for the virulent DEV strain and 493 bp for the attenuated strain.
bThe PCR fragment is 2454 bp for the virulent DEV strain and 573 bp for the attenuated strain.